Jared Gollob, MD, Chief Medical Officer of Kymera Therapeutics, spoke with Dermatology Times to discuss these trial results.
Jared Gollob, MD
Advertisement
Articles by Jared Gollob, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Dupilumab Demonstrates Positive Effects on TCS Use, Growth in Pediatric Patients
2
Topical and Systemic Tools Expand Options for Hair Loss, Pigmentary Disorders, and Hand Eczema
3
Pilot Study Tests Oral NAC as Adjunct in Vitiligo Therapy
4
Day 1 Recap: Elevate-Derm Fall Conference
5
